 | • レポートコード：QFJ1-5442 • 出版社/出版日：QYResearch / 2021年6月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、117ページ • 納品方法：Eメール（納期：3日） • 産業分類：新技術 |
| Single User | ￥585,000 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥877,500 (USD5,850) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の本調査レポートでは、新型コロナウイルス感染症用治療薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（錠剤、注射）、用途別市場規模（軽度症状患者、重篤症状患者、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。 ・市場概要 ・新型コロナウイルス感染症用治療薬の市場動向 ・企業の競争状況、市場シェア ・新型コロナウイルス感染症用治療薬の種類別市場規模と予測2016-2027（錠剤、注射） ・新型コロナウイルス感染症用治療薬の用途別市場規模と予測2016-2027（軽度症状患者、重篤症状患者、その他） ・新型コロナウイルス感染症用治療薬の北米市場規模2016-2027（アメリカ、カナダ） ・新型コロナウイルス感染症用治療薬の欧州市場規模2016-2027（ドイツ、フランス、イギリス等） ・新型コロナウイルス感染症用治療薬のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・新型コロナウイルス感染症用治療薬の中南米市場規模2016-2027（メキシコ、ブラジル） ・新型コロナウイルス感染症用治療薬の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Advanz Pharma、Kyung Poong、Mylan、Novartis、Sanofi、Apotex、Bayer、Guangzhou Baiyunshan Guanghua Pharmaceutical、Ipca Laboratories、Sichuan Sunny Hope、Zydus Cadila、Teva、Sun Pharma、Rising Pharmaceutical、KPC Group、Bristol Laboratories、Shanghai Zhongxisanwei、Shanghai Pharma） ・結論 |
In 2021, the global COVID-19 Medicine market size will be US$ XX million and it is expected to reach US$ XX million by the end of 2027, with a CAGR of XX% during 2021-2027.
This report focuses on the global COVID-19 Medicine status, future forecast, growth opportunity, key market, and key players. The study objectives are to present the COVID-19 Medicine development in North America, Europe, Japan, China, Southeast Asia, India, etc.
Global COVID-19 Medicine Scope and Market Size
COVID-19 Medicine market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global COVID-19 Medicine market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
Tablet
Injection
Segment by Application
Patients With Mild Symptoms
Critically Ill
Other
By Region
North America
Europe
Japan
China
Southeast Asia
India
By Company
Advanz Pharma
Kyung Poong
Mylan
Novartis
Sanofi
Apotex
Bayer
Guangzhou Baiyunshan Guanghua Pharmaceutical
Ipca Laboratories
Sichuan Sunny Hope
Zydus Cadila
Teva
Sun Pharma
Rising Pharmaceutical
KPC Group
Bristol Laboratories
Shanghai Zhongxisanwei
Shanghai Pharma
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global COVID-19 Medicine Market Size Growth Rate by Type (2021-2027)
1.2.2 Tablet
1.2.3 Injection
1.3 Market by Application
1.3.1 Global COVID-19 Medicine Market Share by Application (2021-2027)
1.3.2 Patients With Mild Symptoms
1.3.3 Critically Ill
1.3.4 Other
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global COVID-19 Medicine Market Size
2.2 COVID-19 Medicine Market Size by Regions
2.2.1 COVID-19 Medicine Growth Rate by Regions (2021-2027)
2.2.2 COVID-19 Medicine Market Share by Regions (2021-2027)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Use Cases
3 Key Players
3.1 COVID-19 Medicine Revenue by Players (2020-2021)
3.2 COVID-19 Medicine Key Players Headquaters and Area Served
3.3 Key Players COVID-19 Medicine Product/Solution/Service
3.4 Date of Enter into COVID-19 Medicine Market
3.5 Mergers & Acquisitions, Expansion Plans
4 Breakdown by Type and by Application
4.1 Global COVID-19 Medicine Market Size by Type (2021-2027)
4.2 Global COVID-19 Medicine Market Size by Application (2021-2027)
5 North America
5.1 North America COVID-19 Medicine Market Forecast (2021-2027)
5.2 COVID-19 Medicine Key Players in North America
5.3 North America COVID-19 Medicine Market Size by Type
5.4 North America COVID-19 Medicine Market Size by Application
6.4.4 Canada
6 Europe
6.1 Europe COVID-19 Medicine Market Forecast (2021-2027)
6.2 COVID-19 Medicine Key Players in Europe
6.3 Europe COVID-19 Medicine Market Size by Type
6.4 Europe COVID-19 Medicine Market Size by Application
7 Japan
7.1 Japan COVID-19 Medicine Market Forecast (2021-2027)
7.2 COVID-19 Medicine Key Players in Europe
7.3 Japan COVID-19 Medicine Market Size by Type
7.4 Japan COVID-19 Medicine Market Size by Application
8 Rest of World
8.1 China
8.1.1 China COVID-19 Medicine Market Analysis
8.1.2 Key Players in China
8.2 Southeast Asia
8.2.1 Southeast Asia COVID-19 Medicine Market Analysis
8.2.2 Key Players in Southeast Asia
8.3 India
8.3.1 India COVID-19 Medicine Market Analysis
8.3.2 Key Players in India
9 International Player Profiles
9.1 Advanz Pharma
9.1.1 Advanz Pharma Company Details
9.1.2 Advanz Pharma Description and Business Overview
9.1.3 Advanz Pharma COVID-19 Medicine Introduction
9.1.4 Advanz Pharma Revenue in COVID-19 Medicine Business (2020-2021)
9.1.5 Advanz Pharma Recent Development
9.2 Kyung Poong
9.2.1 Kyung Poong Company Details
9.2.2 Kyung Poong Description and Business Overview
9.2.3 Kyung Poong COVID-19 Medicine Introduction
9.2.4 Kyung Poong Revenue in COVID-19 Medicine Business (2020-2021)
9.2.5 Kyung Poong Recent Development
9.3 Mylan
9.3.1 Mylan Company Details
9.3.2 Mylan Description and Business Overview
9.3.3 Mylan COVID-19 Medicine Introduction
9.3.4 Mylan Revenue in COVID-19 Medicine Business (2020-2021)
9.3.5 Mylan Recent Development
9.4 Novartis
9.4.1 Novartis Company Details
9.4.2 Novartis Description and Business Overview
9.4.3 Novartis COVID-19 Medicine Introduction
9.4.4 Novartis Revenue in COVID-19 Medicine Business (2020-2021)
9.4.5 Novartis Recent Development
9.5 Sanofi
9.5.1 Sanofi Company Details
9.5.2 Sanofi Description and Business Overview
9.5.3 Sanofi COVID-19 Medicine Introduction
9.5.4 Sanofi Revenue in COVID-19 Medicine Business (2020-2021)
9.5.5 Sanofi Recent Development
9.6 Apotex
9.6.1 Apotex Company Details
9.6.2 Apotex Description and Business Overview
9.6.3 Apotex COVID-19 Medicine Introduction
9.6.4 Apotex Revenue in COVID-19 Medicine Business (2020-2021)
9.6.5 Apotex Recent Development
9.7 Bayer
9.7.1 Bayer Company Details
9.7.2 Bayer Description and Business Overview
9.7.3 Bayer COVID-19 Medicine Introduction
9.7.4 Bayer Revenue in COVID-19 Medicine Business (2020-2021)
9.7.5 Bayer Recent Development
9.8 Guangzhou Baiyunshan Guanghua Pharmaceutical
9.8.1 Guangzhou Baiyunshan Guanghua Pharmaceutical Company Details
9.8.2 Guangzhou Baiyunshan Guanghua Pharmaceutical Description and Business Overview
9.8.3 Guangzhou Baiyunshan Guanghua Pharmaceutical COVID-19 Medicine Introduction
9.8.4 Guangzhou Baiyunshan Guanghua Pharmaceutical Revenue in COVID-19 Medicine Business (2020-2021)
9.8.5 Guangzhou Baiyunshan Guanghua Pharmaceutical Recent Development
9.9 Ipca Laboratories
9.9.1 Ipca Laboratories Company Details
9.9.2 Ipca Laboratories Description and Business Overview
9.9.3 Ipca Laboratories COVID-19 Medicine Introduction
9.9.4 Ipca Laboratories Revenue in COVID-19 Medicine Business (2020-2021)
9.9.5 Ipca Laboratories Recent Development
9.10 Sichuan Sunny Hope
9.10.1 Sichuan Sunny Hope Company Details
9.10.2 Sichuan Sunny Hope Description and Business Overview
9.10.3 Sichuan Sunny Hope COVID-19 Medicine Introduction
9.10.4 Sichuan Sunny Hope Revenue in COVID-19 Medicine Business (2020-2021)
9.10.5 Sichuan Sunny Hope Recent Development
9.11 Zydus Cadila
9.11.1 Zydus Cadila Company Details
9.11.2 Zydus Cadila Description and Business Overview
9.11.3 Zydus Cadila COVID-19 Medicine Introduction
9.11.4 Zydus Cadila Revenue in COVID-19 Medicine Business (2020-2021)
9.11.5 Zydus Cadila Recent Development
9.12 Teva
9.12.1 Teva Company Details
9.12.2 Teva Description and Business Overview
9.12.3 Teva COVID-19 Medicine Introduction
9.12.4 Teva Revenue in COVID-19 Medicine Business (2020-2021)
9.12.5 Teva Recent Development
9.13 Sun Pharma
9.13.1 Sun Pharma Company Details
9.13.2 Sun Pharma Description and Business Overview
9.13.3 Sun Pharma COVID-19 Medicine Introduction
9.13.4 Sun Pharma Revenue in COVID-19 Medicine Business (2020-2021)
9.13.5 Sun Pharma Recent Development
9.14 Rising Pharmaceutical
9.14.1 Rising Pharmaceutical Company Details
9.14.2 Rising Pharmaceutical Description and Business Overview
9.14.3 Rising Pharmaceutical COVID-19 Medicine Introduction
9.14.4 Rising Pharmaceutical Revenue in COVID-19 Medicine Business (2020-2021)
9.14.5 Rising Pharmaceutical Recent Development
9.15 KPC Group
9.15.1 KPC Group Company Details
9.15.2 KPC Group Description and Business Overview
9.15.3 KPC Group COVID-19 Medicine Introduction
9.15.4 KPC Group Revenue in COVID-19 Medicine Business (2020-2021)
9.15.5 KPC Group Recent Development
9.16 Bristol Laboratories
9.16.1 Company Details
9.16.2 Bristol Laboratories Description and Business Overview
9.16.3 Bristol Laboratories COVID-19 Medicine Introduction
9.16.4 Bristol Laboratories Revenue in COVID-19 Medicine Business (2020-2021)
9.16.5 Bristol Laboratories Recent Development
9.17 Shanghai Zhongxisanwei
9.17.1 Shanghai Zhongxisanwei Company Details
9.17.2 Shanghai Zhongxisanwei Description and Business Overview
9.17.3 Shanghai Zhongxisanwei COVID-19 Medicine Introduction
9.17.4 Shanghai Zhongxisanwei Revenue in COVID-19 Medicine Business (2020-2021)
9.17.5 Shanghai Zhongxisanwei Recent Development
9.18 Shanghai Pharma
9.18.1 Shanghai Pharma Company Details
9.18.2 Shanghai Pharma Description and Business Overview
9.18.3 Shanghai Pharma COVID-19 Medicine Introduction
9.18.4 Shanghai Pharma Revenue in COVID-19 Medicine Business (2020-2021)
9.18.5 Shanghai Pharma Recent Development
10 Market Dynamics
10.1 Industry Trends
10.2 Market Drives
10.3 Market Challenges
10.4 Market Restraints
11 Key Findings in This Report
12 Appendix
12.1 Research Methodology
12.1.1 Methodology/Research Approach
12.1.2 Data Source
12.2 Disclaimer
12.3 Author Details
Table 1. Global COVID-19 Medicine Market Size Growth Rate by Type (2021-2027) (US$ Million)
Table 2. Key Players of Tablet
Table 3. Key Players of Injection
Table 4. Global COVID-19 Medicine Market Size Growth by Application (2021-2027) (US$ Million)
Table 5. Global COVID-19 Medicine Market Size by Regions (2021-2027) (US$ Million)
Table 6. Global COVID-19 Medicine Market Share by Regions (2021-2027)
Table 7. Market Top Trends
Table 8. Market Use Cases
Table 9. Global COVID-19 Medicine Revenue by Players (2020-2021) (US$ Million)
Table 10. Global COVID-19 Medicine Market Share by Players (2020-2021)
Table 11. Key Players Headquarters and Area Served
Table 12. Key Players COVID-19 Medicine Product Solution and Service
Table 13. Date of Enter into COVID-19 Medicine Market
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Global COVID-19 Medicine Market Size by Type (2021-2027) (US$ Million)
Table 16. Global COVID-19 Medicine Market Size Share by Type (2021-2027)
Table 17. Global COVID-19 Medicine Market Size by Application (2021-2027) (US$ Million)
Table 18. Global COVID-19 Medicine Market Size Share by Application (2021-2027)
Table 19. North America Key Players COVID-19 Medicine Revenue (2020-2021) (US$ Million)
Table 20. North America Key Players COVID-19 Medicine Market Share (2020-2021)
Table 21. North America COVID-19 Medicine Market Size by Type (2021-2027) (US$ Million)
Table 22. North America COVID-19 Medicine Market Share by Type (2021-2027)
Table 23. North America COVID-19 Medicine Market Size by Application (2021-2027) (US$ Million)
Table 24. North America COVID-19 Medicine Market Share by Application (2021-2027)
Table 25. Europe Key Players COVID-19 Medicine Revenue (2020-2021) (US$ Million)
Table 26. Europe Key Players COVID-19 Medicine Market Share (2020-2021)
Table 27. Europe COVID-19 Medicine Market Size by Type (2021-2027) (US$ Million)
Table 28. Europe COVID-19 Medicine Market Share by Type (2021-2027)
Table 29. Europe COVID-19 Medicine Market Size by Application (2021-2027) (US$ Million)
Table 30. Europe COVID-19 Medicine Market Share by Application (2021-2027)
Table 31. Japan Key Players COVID-19 Medicine Revenue (2020-2021) (US$ Million)
Table 32. Japan Key Players COVID-19 Medicine Market Share (2020-2021)
Table 33. Japan COVID-19 Medicine Market Size by Type (2021-2027) (US$ Million)
Table 34. Japan COVID-19 Medicine Market Share by Type (2021-2027)
Table 35. Japan COVID-19 Medicine Market Size by Application (2021-2027) (US$ Million)
Table 36. Japan COVID-19 Medicine Market Share by Application (2021-2027)
Table 37. Key Players in China
Table 38. Key Players in Southeast Asia
Table 39. Key Players in India
Table 40. Advanz Pharma Company Details
Table 41. Advanz Pharma Description and Business Overview
Table 42. Advanz Pharma COVID-19 Medicine Product
Table 43. Advanz Pharma Revenue in COVID-19 Medicine Business 2020 and 2021
Table 44. Advanz Pharma Recent Development
Table 45. Kyung Poong Company Details
Table 46. Kyung Poong Description and Business Overview
Table 47. Kyung Poong COVID-19 Medicine Product
Table 48. Kyung Poong Revenue in COVID-19 Medicine Business 2020 and 2021
Table 49. Kyung Poong Recent Development
Table 50. Mylan Company Details
Table 51. Mylan Description and Business Overview
Table 52. Mylan COVID-19 Medicine Product
Table 53. Mylan Revenue in COVID-19 Medicine Business 2020 and 2021
Table 54. Mylan Recent Development
Table 55. Novartis Company Details
Table 56. Novartis Description and Business Overview
Table 57. Novartis COVID-19 Medicine Product
Table 58. Novartis Revenue in COVID-19 Medicine Business 2020 and 2021
Table 59. Novartis Recent Development
Table 60. Sanofi Company Details
Table 61. Sanofi Description and Business Overview
Table 62. Sanofi COVID-19 Medicine Product
Table 63. Sanofi Revenue in COVID-19 Medicine Business 2020 and 2021
Table 64. Sanofi Recent Development
Table 65. Apotex Company Details
Table 66. Apotex Description and Business Overview
Table 67. Apotex COVID-19 Medicine Product
Table 68. Apotex Revenue in COVID-19 Medicine Business 2020 and 2021
Table 69. Apotex Recent Development
Table 70. Bayer Company Details
Table 71. Bayer Description and Business Overview
Table 72. Bayer COVID-19 Medicine Product
Table 73. Bayer Revenue in COVID-19 Medicine Business 2020 and 2021
Table 74. Bayer Recent Development
Table 75. Guangzhou Baiyunshan Guanghua Pharmaceutical Company Details
Table 76. Guangzhou Baiyunshan Guanghua Pharmaceutical Description and Business Overview
Table 77. Guangzhou Baiyunshan Guanghua Pharmaceutical COVID-19 Medicine Product
Table 78. Guangzhou Baiyunshan Guanghua Pharmaceutical Revenue in COVID-19 Medicine Business 2020 and 2021
Table 79. Guangzhou Baiyunshan Guanghua Pharmaceutical Recent Development
Table 80. Ipca Laboratories Company Details
Table 81. Ipca Laboratories Description and Business Overview
Table 82. Ipca Laboratories COVID-19 Medicine Product
Table 83. Ipca Laboratories Revenue in COVID-19 Medicine Business 2020 and 2021
Table 84. Ipca Laboratories Recent Development
Table 85. Sichuan Sunny Hope Company Details
Table 86. Sichuan Sunny Hope Description and Business Overview
Table 87. Sichuan Sunny Hope COVID-19 Medicine Product
Table 88. Sichuan Sunny Hope Revenue in COVID-19 Medicine Business 2020 and 2021
Table 89. Sichuan Sunny Hope Recent Development
Table 90. Zydus Cadila Company Details
Table 91. Zydus Cadila Description and Business Overview
Table 92. Zydus Cadila COVID-19 Medicine Product
Table 93. Zydus Cadila Revenue in COVID-19 Medicine Business 2020 and 2021
Table 94. Zydus Cadila Recent Development
Table 95. Teva Company Details
Table 96. Teva Description and Business Overview
Table 97. Teva COVID-19 Medicine Product
Table 98. Teva Revenue in COVID-19 Medicine Business 2020 and 2021
Table 99. Teva Recent Development
Table 100. Sun Pharma Company Details
Table 101. Sun Pharma Description and Business Overview
Table 102. Sun Pharma COVID-19 Medicine Product
Table 103. Sun Pharma Revenue in COVID-19 Medicine Business 2020 and 2021
Table 104. Sun Pharma Recent Development
Table 105. Rising Pharmaceutical Company Details
Table 106. Rising Pharmaceutical Description and Business Overview
Table 107. Rising Pharmaceutical COVID-19 Medicine Product
Table 108. Rising Pharmaceutical Revenue in COVID-19 Medicine Business 2020 and 2021
Table 109. Rising Pharmaceutical Recent Development
Table 110. KPC Group Company Details
Table 111. KPC Group Description and Business Overview
Table 112. KPC Group COVID-19 Medicine Product
Table 113. KPC Group Revenue in COVID-19 Medicine Business 2020 and 2021
Table 114. KPC Group Recent Development
Table 115. Bristol Laboratories Company Details
Table 116. Bristol Laboratories Description and Business Overview
Table 117. Bristol Laboratories COVID-19 Medicine Product
Table 118. Bristol Laboratories Revenue in COVID-19 Medicine Business 2020 and 2021
Table 119. Bristol Laboratories Recent Development
Table 120. Shanghai Zhongxisanwei Company Details
Table 121. Shanghai Zhongxisanwei Description and Business Overview
Table 122. Shanghai Zhongxisanwei COVID-19 Medicine Product
Table 123. Shanghai Zhongxisanwei Revenue in COVID-19 Medicine Business 2020 and 2021
Table 124. Shanghai Zhongxisanwei Recent Development
Table 125. Shanghai Pharma Company Details
Table 126. Shanghai Pharma Description and Business Overview
Table 127. Shanghai Pharma COVID-19 Medicine Product
Table 128. Shanghai Pharma Revenue in COVID-19 Medicine Business 2020 and 2021
Table 129. Shanghai Pharma Recent Development
Table 130. COVID-19 Medicine Market Trends
Table 131. COVID-19 Medicine Market Drivers
Table 132. COVID-19 Medicine Market Challenges
Table 133. COVID-19 Medicine Market Restraints
Table 134. Research Programs/Design for This Report
Table 135. Key Data Information from Secondary Sources
Table 136. Key Data Information from Primary Sources
List of Figures
Figure 1. Global COVID-19 Medicine Market Share by Type in 2021 & 2027
Figure 2. Tablet Features
Figure 3. Injection Features
Figure 4. Global COVID-19 Medicine Market Share by Application in 2021 & 2027
Figure 5. Patients With Mild Symptoms Case Studies
Figure 6. Critically Ill Case Studies
Figure 7. Other Case Studies
Figure 8. COVID-19 Medicine Report Years Considered
Figure 9. Global COVID-19 Medicine Market Size and Growth Rate (2020-2027) (US$ Million)
Figure 10. Global COVID-19 Medicine Market Share by Regions (2020-2027)
Figure 11. Global COVID-19 Medicine Market Share by Players in 2021
Figure 12. Global COVID-19 Medicine Market Size Market Share by Type (2021-2027)
Figure 13. Global COVID-19 Medicine Market Size Market Share by Application (2021-2027)
Figure 14. Global COVID-19 Medicine Revenue Market Share by Application in 2021
Figure 15. North America COVID-19 Medicine Market Size 2021-2027 (US$ Million)
Figure 16. Europe COVID-19 Medicine Market Size 2021-2027 (US$ Million)
Figure 17. Japan COVID-19 Medicine Market Size 2021-2027 (US$ Million)
Figure 18. COVID-19 Medicine Market Size in China (2021-2027) (US$ Million)
Figure 19. COVID-19 Medicine Market Size in Southeast Asia (2021-2027) (US$ Million)
Figure 20. COVID-19 Medicine Market Size in India (2021-2027) (US$ Million)
Figure 21. Bottom-up and Top-down Approaches for This Report
Figure 22. Data Triangulation
Figure 23. Key Executives Interviewed
世界の新型コロナウイルス感染症用従来型漢方薬市場規模・現状・予測（2021年-2027年） At present, the global COVID-19 epidemic is progressing rapidly. Chinese medicine has a long history and plays an indispensable role in the prevention and treatment of various epidemics. During the treatment of COVID-19, the intervention of Chinese medicine has also achieved remarkable results. In 2…- 世界の新型コロナウイルス感染症治療市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Covid-19 Treatments Market The global Covid-19 Treatments market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in analysis and high data integrity, the report mak…
- 世界の新型コロナウイルス感染症用中国製医薬品市場規模・現状・予測（2021年-2027年） In 2021, the global Chinese Materia Medica for COVID-19 market size will be US$ XX million and it is expected to reach US$ XX million by the end of 2027, with a CAGR of XX% during 2021-2027. This report focuses on the global Chinese Materia Medica for COVID-19 status, future forecast, growth opportu…
- 世界の新型コロナウイルス感染症診断市場規模・現状・予測（2021年-2027年） The COVID-19 pandemic has been declared as a global health crisis by WHO and is one of the greatest challenges ever faced by mankind since World War II. After its emergence in Wuhan, China by the end of December 2019, the virus has spread across 184 countries through the first quarter of 2020. Incid…
- 世界の新型コロナウイルス感染症用医薬品API市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global COVID-19 Drug API Market The global COVID-19 Drug API market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in analysis and high data integrity, the report makes a…